Patent classifications
C07F9/38
ACIDIC HYBRID MONOMERS AND DENTAL MATERIALS BASED THEREON
Acidic monomer according to Formula I:
##STR00001##
in which A is a linear or branched aliphatic C.sub.1-C.sub.18-hydrocarbon group, which can be interrupted by one or more —O—, —S—, —CO—O—, —O—CO—NH—, —HN—CO—NH— or —CO—NR.sup.1—; R.sup.1 is H or a C.sub.1-C.sub.6 alkyl group; X is absent or is a linear or branched aliphatic C.sub.1-C.sub.10 hydrocarbon group, which can be interrupted by one or more —O—, —S—, —CO—O—, —O—CO—NH—, —HN—CO—NH— or —CO—NR.sup.2—; R.sup.2 is H or a C.sub.1-C.sub.6 alkyl group; PG is a radically polymerizable group, preferably vinyl, allyl, CH.sub.2═CR.sup.3—CO—Y— or R.sup.4O—CO—C(═CH.sub.2)—CH.sub.2—Y—; Y═O or NR.sup.5 or is absent; R.sup.3 is H or CH.sub.3; R.sup.4 is H or a C.sub.1-C.sub.7 alkyl group; R.sup.5 is H or a C.sub.1-C.sub.7 alkyl group; n is 1, 2, 3 or 4; m=1 or 2; p=1, 2 or 3; and q=1, 2 or 3. The monomers are particularly suitable as components of dental material.
Guanidine derivative compounds
The present invention provides guanidine compounds and salts thereof that may be useful, for example, in the preparation of herbicidal compositions. The compounds may be used, for example, to prepare N-phosphonomethylglycine guanidine salts having improved herbicidal efficacy over glyphosate alone.
Method for the synthesis of ethane-1-hydroxy-1,1-diphosphonic acid
The present invention is related to a method for the synthesis of ethane-1-hydroxy-1,1-diphosphonic acid or its salt which includes the steps of reacting tetraphosphorus hexaoxide and acetic acid under controlled reaction conditions; hydrolyzing the formed ethane-1-hydroxy-1,1-diphosphonic acid condensates to form ethane-1-hydroxy-1,1-diphosphonic acid; further processing the ethane-1-hydroxy-1,1-diphosphonic acid solution. The process according to the method of the present invention is highly controllable and further is characterized by a high selectivity.
Therapeutic bisphosphonates
The invention provides novel pyrophosphate synthase inhibitors of formula I and formula II as well salts thereof; the invention also provides compositions comprising such inhibitors and methods for their use. ##STR00001##
Phosphorus containing flame retardants
Certain phosphonic acid salts heated at temperatures over 200° C. generate thermally stable, highly efficient flame retardant materials well suited for use as flame retardant additives in polymers. The flame retardants of the invention can be used as the sole flame retardant in a composition or in combination with other flame retardants, synergists or adjuvants.
ELECTROCHROMIC ELEMENT AND ELECTROCHROMIC DIMMING ELEMENT
To provide an electrochromic element, which contains: a first electrode; a second electrode; and an electrolyte provided between the first electrode and the second electrode, wherein the first electrode contains a polymer product obtained through polymerization of an electrochromic composition where the electrochromic composition contains a radical polymerizable compound containing triarylamine.
Versatile Non-Destructive Surface Modification of Carbonaceous Materials and Process for Grafting Into Polymer Matrices
Disclosed is a non-destructive universal method of functionalization of graphitic carbonaceous materials that enables their alignment, cross-linking, and effective integration into composite materials.
Fused pyrimidine derivatives for inhibition of tyrosine kinase activity
The present invention relates to a novel fused pyrimidine derivative having an inhibitory activity for tyrosine kinases, and a pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immunologically mediated diseases comprising same as an active ingredient.
Endosseous implant
Endosseous implant to be applied to a human or animal bone, wherein the surface of the implant is made from titanium or a titanium alloy, said implant having a smooth or rough surface texture, which is characterized in that said surface has been treated with at least one selected organic phosphonate compound or a pharmaceutically acceptable salt or ester or an amide thereof; process for producing said implants.
ANTI-INFECTIVE FUNCTIONALIZED SURFACES AND METHODS OF MAKING SAME
Devices are provided which are functionalized to include surface regions having anti-infective agents. Methods are provided for functionalizing various material surfaces to include active surface regions for binding anti-infective agents. Methods are provided by which anti-infective moieties or agents are bonded to functionalized surfaces.